1386459-84-2

Usage

Uses

Used in Medicinal Chemistry:
(5-bromo-3-chloro-2-fluorophenyl)methanamine is used as a potential drug candidate in the field of medicinal chemistry due to its distinctive chemical properties. Its halogenated structure allows for the development of new pharmaceutical compounds with specific therapeutic targets.
Used in Organic Synthesis:
In the realm of organic synthesis, (5-bromo-3-chloro-2-fluorophenyl)methanamine serves as a building block for creating more complex molecules. Its versatile structure facilitates the synthesis of a wide range of compounds, making it a valuable precursor in chemical research and development.
Used in Pharmaceutical Compounds and Agrochemicals:
The presence of multiple halogen atoms in (5-bromo-3-chloro-2-fluorophenyl)methanamine makes it a useful precursor for the synthesis of various pharmaceutical compounds and agrochemicals. Its unique structure can be exploited to design and develop novel molecules with specific biological activities and applications.
Used in Biological Activity Studies:
Due to its potential biological activity, (5-bromo-3-chloro-2-fluorophenyl)methanamine can be studied for its pharmacological properties. This may lead to the discovery of new therapeutic agents or the enhancement of existing ones, contributing to the advancement of medical treatments and healthcare solutions.

Upstream product

• 1280786-80-2 5-bromo-3-chloro-2-fluorobenzaldehyde 
• 60811-21-4 1-bromo-3-chloro-4-fluorobenzene 
• 1000577-76-3 5-bromo-3-chloro-2-fluorobenzonitrile 

Downstream Products

• 1386459-85-3 (5-bromo-3-chloro-2-fluoro-benzyl)-carbamic acid tert-butyl ester 
• 1386459-86-4 3-(tert-butoxycarbonylamino-methyl)-5-chloro-4-fluoro-benzoic acid 
• 1386459-87-5 3-(tert-butoxycarbonylamino-methyl)-5-chloro-4-fluoro-benzoic acid methyl ester 
• 1386459-88-6 (3-chloro-5-cyano-2-fluoro-benzyl)-carbamic acid tert-butyl ester 
• 1386459-89-7 [3-chloro-2-fluoro-5-(2H-tetrazol-5-yl)-benzyl]-carbamic acid tert-butyl ester 
• 1386459-91-1 3-aminomethyl-5-chloro-4-fluoro-benzonitrile 
• 1386459-92-2 {3-chloro-2-fluoro-5-[(2-methoxy-ethyl)-methyl-amino]-benzyl}-carbamic acid tert-butyl ester 
• 1386459-93-3 (3-aminomethyl-5-chloro-4-fluoro-phenyl)-(2-methoxy-ethyl)-methyl-amine 
• 1386460-03-2 (3-chloro-2-fluoro-5-vinyl-benzyl)-carbamic acid tert-butyl ester 
• 1386460-04-3 (3-chloro-2-fluoro-5-formyl-benzyl)-carbamic acid tert-butyl ester 
• 1386460-05-4 (3-chloro-5-diethylaminomethyl-2-fluoro-benzyl)-carbamic acid tert-butyl ester 
• 1386460-06-5 (3-aminomethyl-5-chloro-4-fluoro-benzyl)-diethyl-amine 

Relevant academic research and scientific papers

ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS

Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an aryl, heteroaryl or heterocycle (R32) are provided. The inhibitors of Factor D described herein reduce the excessive activation of complement.

INDOLE COMPOUNDS OR ANALOGUES THEREOF USEFUL FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)

The present invention provides a compound of formula (I): a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.